4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-25-003121
President and CEO gave up 19,905 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Blume-Jensen Peter · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-21 | Shares withheld for taxes : show line 1 in the form | −19,905 | $1.32 | $26,275 | 2,126,440 | D |
Loading xslF345X05/form4.xml…